Pfizer UK has launched a new social media campaign urging people not to be “catfished” into buying counterfeit drugs.
Alexion Pharmaceuticals is to acquire immune-system specialist Achillion for almost $1 billion dollars.
Brexit uncertainty is already having a negative impact on UK science, according to The Royal Society, the UK’s national academy of sciences.
Uncertainty surrounding the patentability of artificial intelligence (AI) and changes to patented medicine pricing in Canada were two topics discussed yesterday, October 15 at Life Sciences Patent Network Fall in San Francisco.
Indian chemical manufacturer UPL has been ordered to pay US-based AgroFresh Solutions $31 million after a jury ruled that it had stolen the company’s trade secrets and infringed one of its patents.
The Philippines’ deputy IP chief has warned e-commerce platforms that they could be made liable for the sale of counterfeit goods on their sites under new legislation, amid fears over the spread of counterfeit pharmaceuticals.
US biotechnology company Qrons has obtained a world exclusive licence for IP related to 3D printable materials in the fields of human and animal health from Dartmouth University.
Belgium head-quartered pharmaceutical company UCB is to acquire Ra Pharmaceuticals for approximately $2.1 billion.
Actavis Laboratories cannot market a generic version of Horizon Pharma’s knee pain treatment, an appeals court has ruled.
Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company.